We now show that EZH2 inhibition by UNC1999 reduced MM cell viability and the expression of MM-associated oncogenes; IRF-4, XBP-1, PRDM1 (hereafter BLIMP-1) and c-MYC in MM cell lines. This evidence concerns the gene PRDM1 and Miyoshi myopathy.